X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
3.980
+0.180 (4.74%)
At close: Dec 5, 2025, 4:00 PM EST
3.970
-0.010 (-0.25%)
After-hours: Dec 5, 2025, 6:37 PM EST
X4 Pharmaceuticals Employees
X4 Pharmaceuticals had 143 employees as of December 31, 2024. The number of employees increased by 50 or 53.76% compared to the previous year.
Employees
143
Change (1Y)
50
Growth (1Y)
53.76%
Revenue / Employee
$237,615
Profits / Employee
-$665,000
Market Cap
348.00M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
XFOR News
- 5 days ago - X4 Pharmaceuticals: Betting On Mavorixafor For Chronic Neutropenia - Seeking Alpha
- 4 weeks ago - X4 Pharmaceuticals to Participate in Guggenheim's Second Annual Healthcare Innovation Conference - GlobeNewsWire
- 4 weeks ago - X4 Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 5 weeks ago - X4 Pharmaceuticals Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $155.3 Million - GlobeNewsWire
- 6 weeks ago - X4 Pharmaceuticals Announces Pricing of $135 Million Underwritten Public Offering - GlobeNewsWire
- 6 weeks ago - X4 Pharmaceuticals Announces Proposed Underwritten Public Offering - GlobeNewsWire
- 2 months ago - X4 Pharmaceuticals Announces Restructuring of Business Operations Designed to Drive Long-Term Value Creation - GlobeNewsWire
- 4 months ago - X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire